Medrx Co (TSE:4586) Cyclically Adjusted Book per Share: 円179.90 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4586 Medrx Co Ltd TSE:4586
57 GF Score
Price 円57.00
GF Value 円70.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medrx Co Cyclically Adjusted Book per Share?

Medrx Co TSE:4586 +3.64% 57 Cyclically Adjusted Book per Share is 円179.90 as of Dec. 2025. GuruFocus rates TSE:4586 with a GF Score™ of 57/100 and a GF Value™ of 円70.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medrx Co's adjusted book value per share for the three months ended in Dec. 2025 was 円34.515. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円179.90 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Medrx Co's average Cyclically Adjusted Book Growth Rate was -16.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -15.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Medrx Co was -15.80% per year. The lowest was -15.80% per year. And the median was -15.80% per year.

As of today (2026-07-15), Medrx Co's current stock price is 円57.00. Medrx Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was 円179.90. Medrx Co's Cyclically Adjusted PB Ratio of today is 0.32.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medrx Co was 1.03. The lowest was 0.27. And the median was 0.48.


Medrx Co  (TSE:4586) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medrx Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=57.00/179.90
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medrx Co was 1.03. The lowest was 0.27. And the median was 0.48.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medrx Co Cyclically Adjusted Book per Share Related Terms


Medrx Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medrx Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medrx Co Cyclically Adjusted Book per Share Chart

Medrx Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 301.13 253.39 216.17 179.90

Medrx Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.17 202.96 190.49 179.90 0.00

TSE:4586 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Cyclically Adjusted PB Ratio falls into.


TSE:4586
57GF Score
Medrx Co Ltd TSE:4586
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medrx Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medrx Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=34.515/113.0000*113.0000
=34.515

Current CPI (Dec. 2025) = 113.0000.

Medrx Co Quarterly Data

Book Value per Share CPI Adj_Book
201509 448.291 98.500 514.283
201512 402.392 98.100 463.510
201603 382.579 97.900 441.588
201606 343.623 98.100 395.814
201609 327.876 98.000 378.061
201612 294.364 98.400 338.040
201703 272.654 98.100 314.066
201706 239.228 98.500 274.444
201709 212.171 98.800 242.665
201712 228.803 99.400 260.108
201803 293.632 99.200 334.480
201806 277.422 99.200 316.015
201809 241.368 99.900 273.019
201812 208.597 99.700 236.424
201903 187.007 99.700 211.954
201906 187.473 99.800 212.269
201909 161.413 100.100 182.214
201912 140.063 100.500 157.484
202003 129.396 100.300 145.780
202006 104.928 99.900 118.687
202009 104.868 99.900 118.619
202012 110.496 99.300 125.741
202103 98.911 99.900 111.881
202106 94.917 99.500 107.795
202109 92.548 100.100 104.475
202112 79.508 100.100 89.754
202203 71.558 101.100 79.981
202206 64.202 101.800 71.265
202209 54.883 103.100 60.153
202212 42.967 104.100 46.640
202303 37.538 104.400 40.630
202306 47.729 105.200 51.268
202309 56.899 106.200 60.542
202312 50.169 106.800 53.081
202403 47.839 107.200 50.427
202406 56.603 108.200 59.114
202412 45.689 110.700 46.638
202503 36.413 111.100 37.036
202506 34.995 111.700 35.402
202512 34.515 113.000 34.515

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円179.90 mean?
Medrx Co (TSE:4586) has a Cyclically Adjusted Book per Share of 円179.90 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medrx Co and its competitors.
Is Medrx Co's Cyclically Adjusted Book per Share too high?
Medrx Co's current Cyclically Adjusted Book per Share is 円179.90. Overall, Medrx Co has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medrx Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Medrx Co's Cyclically Adjusted Book per Share of 円179.90 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medrx Co and its competitors. Medrx Co's current Cyclically Adjusted Book per Share is 円179.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medrx Co stock overvalued right now?
Based on GuruFocus' analysis, Medrx Co (TSE:4586) is currently considered Modestly Undervalued. The stock's GF Value™ is 円70.55, compared to a current price of 円57.00 — trading 19.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円179.90. Medrx Co's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medrx Co (TSE:4586), the current Cyclically Adjusted Book per Share is 円179.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medrx Co (TSE:4586) Overvalued in 2026?

Based on GuruFocus' analysis, Medrx Co stock appears to be undervalued. The current stock price of 円57.00 is trading 19.2% below its estimated GF Value™ of 円70.55. GuruFocus considers Medrx Co to be Modestly Undervalued.

Key valuation signals for TSE:4586:

  • Cyclically Adjusted Book per Share: 円179.90
  • GF Value™: 円70.55 vs. price of 円57.00 (19.2% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the TSE:4586 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medrx Co Business Description

Address 431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.
57GF Score

Get the complete analysis for TSE:4586

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円57.00
Price
円70.55
GF Value